Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jen-Chung Ko Meng-Rui Lee Jin-Yuan Shih Sheng-Kai Liang |
| Publication date | May 4, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |